Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond.

Dalager-Pedersen, Michael

Dalager-Pedersen, Michael.

Dalager-Pedersen M; Department of Infectious Diseases, Aalborg University Hospital, Aalborg 9000, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg 9000, Denmark. Electronic address: midp@rn.dk.

Clin Microbiol Infect ; 28(9): 1184-1186, 2022 09.

Article in English | MEDLINE | ID: covidwho-1944642

Subject(s)

COVID-19; Pulmonary Embolism; Venous Thromboembolism; Anticoagulants/therapeutic use; Humans; Inpatients; Venous Thromboembolism/drug therapy; Venous Thromboembolism/prevention & control

Keywords

Anticoagulation; COVID-19; Deep venous thrombosis; Pulmonary embolism; Thromboembolism; Thromboprophylaxis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Embolism / Venous Thromboembolism / COVID-19 Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google